Inactivation of CtIP Leads to Early Embryonic Lethality Mediated by G₁ Restraint and to Tumorigenesis by Haploid Insufficiency

REFERENCES

• Bell, S. P., and A. Dutta. 2002. DNA replication in eukaryotic cells. Annu. Rev. Biochem. 71:333–374.
   PubMed Web of Science ®Google Scholar
• Boyd, J. M., T. Subramanian, U. Schaeper, M. La Regina, S. Bayley, and G. Chinnadurai. 1993. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phos-phoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J. 12:469–478.
   PubMed Web of Science ®Google Scholar
• Chinnadurai, G. 2002. CtBP family proteins: more than transcriptional corepressors. BioEssays 25:9–12.
   Google Scholar
• Classon, M., and E. Harlow. 2002. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer 2:910–917.
   PubMed Web of Science ®Google Scholar
• Collins, N., R. A. Poot1, I. Kukimoto, C. García-Jiménez1, G. Dellaire, and P. D. Varga-Weisz1. 2002. An ACF1-ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin. Nat. Genet. 32:627–632.
   PubMed Web of Science ®Google Scholar
• Decesse, J. T., S. Medjkane, M. B. Datto, and C. E. Cremisi. 2001. RB regulates transcription of the p21/WAF1/CIP1 gene. Oncogene 20:962–971.
   PubMedGoogle Scholar
• Dubin, M. J., P. H. Stokes, E. Y. Sum, R. S. Williams, V. A. Valova, P. J. Robinson, G. J. Lindeman, J. N. Glover, J. E. Visvader, and J. M. Matthews. 2004. Dimerization of CtIP, a BRCA1- and CtBP-interacting protein, is mediated by an N-terminal coiled-coil motif. J. Biol. Chem. 279:26932–26938.
   PubMedGoogle Scholar
• Fusco, C., A. Reymond, and A. S. Zervos. 1998. Molecular cloning and characterization of a novel retinoblastoma-binding protein. Genomics 51:351–358.
   PubMed Web of Science ®Google Scholar
• Georgopoulos, K., M. Bigby, J. H. Wang, A. Molnar, P. Wu, S. Winandy, and A. Sharpe. 1994. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79:143–156.
   PubMed Web of Science ®Google Scholar
• Gomez-del Arco, P., K. Maki, and K. Georgopoulos. 2004. Phosphorylation controls Ikaros's ability to negatively regulate the G1-S transition. Mol. Cell. Biol. 24:2797–2807.
   PubMedGoogle Scholar
• Goodrich, D. W., N. P. Wang, Y. W. Qian, E. Y. Lee, and W. H. Lee. 1991. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293–302.
   PubMed Web of Science ®Google Scholar
• Hakem, R., J. L. de la Pompa, C. Sirard, R. Mo, M. Woo, A. Hakem, A. Wakeham, J. Potter, A. Reitmair, F. Billia, E. Firpo, C. C. Hui, J. Roberts, J. Rossant, and T. W. Mak. 1996. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85:1009–1023.
   PubMed Web of Science ®Google Scholar
• He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509–2514.
   PubMed Web of Science ®Google Scholar
• Hildebrand, J. D., and P. Soriano. 2002. Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development. Mol. Cell. Biol. 22:5296–5307.
   PubMed Web of Science ®Google Scholar
• Hoek, M., and B. Stillman. 2003. Chromatin assembly factor 1 is essential and couples chromatin assembly to DNA replication in vivo. Proc. Natl. Acad. Sci. USA 100:12183–12188.
   PubMed Web of Science ®Google Scholar
• Inoue, K., F. Zindy, D. H. Randle, J. E. Rehg, and C. J. Sherr. 2001. Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas. Genes Dev. 15:2934–2939.
   PubMed Web of Science ®Google Scholar
• Jiang, Z., and E. Zacksenhaus. 2002. Activation of retinoblastoma protein in mammary gland leads to ductal growth suppression, precocious differentiation, and adenocarcinoma. J. Cell Biol. 156:185–198.
   PubMed Web of Science ®Google Scholar
• Knudson, A. G. J. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68:820–823.
   PubMed Web of Science ®Google Scholar
• Koipally, J., and K. Georgopoulos. 2002. Ikaros-CtIP interactions do not require C-terminal binding protein and participate in a deacetylase-independent mode of repression. J. Biol. Chem. 277:23143–23149.
   PubMedGoogle Scholar
• Koipally, J., A. Renold, J. Kim, and K. Georgopoulos. 1999. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J. 18:3090–3100.
   PubMedGoogle Scholar
• Lee, E. Y., C. Y. Chang, N. Hu, Y. C. Wang, C. C. Lai, K. Herrup, W. H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288–294.
   PubMed Web of Science ®Google Scholar
• Li, S., P. L. Chen, T. Subramanian, G. Chinnadurai, G. Tomlinson, C. K. Osborne, Z. D. Sharp, and W. H. Lee. 1999. Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J. Biol. Chem. 274:11334–11338.
   PubMed Web of Science ®Google Scholar
• Li, S., N. S. Ting, L. Zheng, P. L. Chen, Y. Ziv, Y. Shiloh, E. Y. Lee, and W. H. Lee. 2000. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 406:210–215.
   PubMed Web of Science ®Google Scholar
• Liu, C. Y., A. Flesken-Nikitin, S. Li, Y. Zeng, and W. H. Lee. 1996. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10:1835–1843.
   PubMed Web of Science ®Google Scholar
• Markey, M. P., S. P. Angus, M. W. Strobeck, S. L. Williams, R. W. Gunawardena, B. J. Aronow, and E. S. Knudsen. 2002. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action. Cancer Res. 62:6587–6597.
   PubMed Web of Science ®Google Scholar
• McNairn, A. J., and D. M. Gilbert. 2003. Epigenomic replication: linking epigenetics to DNA replication. BioEssays 25:647–656.
   PubMedGoogle Scholar
• Meloni, A. R., E. J. Smith, and J. R. Nevins. 1999. A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor. Proc. Natl. Acad. Sci. USA 96:9574–9579.
   PubMedGoogle Scholar
• Peng, A., and P. L. Chen. 2003. NFBD1, like 53BP1, is an early and redundant transducer mediating Chk2 phosphorylation in response to DNA damage. J. Biol. Chem. 278:8873–8876.
   PubMed Web of Science ®Google Scholar
• Pennaneach, V., I. Salles-Passador, A. Munshi, H. Brickner, K. Regazzoni, F. Dick, N. Dyson, T. T. Chen, J. Y. Wang, R. Fotedar, and A. Fotedar. 2001. The large subunit of replication factor C promotes cell survival after DNA damage in an LxCxE motif- and Rb-dependent manner. Mol. Cell 7:715–727.
   PubMedGoogle Scholar
• Rebollo, A., and C. Schmitt. 2003. Ikaros, Aiolos and Helios: transcription regulators and lymphoid malignancies. Immunol. Cell Biol. 81:171–175.
   PubMed Web of Science ®Google Scholar
• Riley, D. J., E. Y. Lee, and W. H. Lee. 1994. The retinoblastoma protein: more than a tumor suppressor. Annu. Rev. Cell Biol. 10:1–29.
   PubMedGoogle Scholar
• Robertson, K. D., S. Ait-Si-Ali, T. Yokochi, P. A. Wade, P. L. Jones, and A. P. Wolffe. 2000. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25:338–342.
   PubMed Web of Science ®Google Scholar
• Schaeper, U., J. M. Boyd, S. Verma, E. Uhlmann, T. Subramanian, and G. Chinnadurai. 1995. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc. Natl. Acad. Sci. USA 92:10467–10471.
   PubMed Web of Science ®Google Scholar
• Schaeper, U., T. Subramanian, L. Lim, J. M. Boyd, and G. Chinnadurai. 1998. Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. J. Biol. Chem. 273:8549–8552.
   PubMed Web of Science ®Google Scholar
• Sheahan, S., C. O. Bellamy, L. Treanor, D. J. Harrison, and S. Prost. 2004. Additive effect of p53, p21 and Rb deletion in triple knockout primary hepatocytes. Oncogene 23:1489–1497.
   PubMed Web of Science ®Google Scholar
• Sterner, J. M., S. Dew-Knight, C. Musahl, S. Kornbluth, and J. M. Horowitz. 1998. Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. Mol. Cell. Biol. 18:2748–2757.
   PubMed Web of Science ®Google Scholar
• Sui, G., C. Soohoo, B. Affar el, F. Gay, Y. Shi, W. C. Forrester, and Y. Shi. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99:5515–5520.
   PubMed Web of Science ®Google Scholar
• Sum, E. Y., B. Peng, X. Yu, J. Chen, J. Byrne, G. J. Lindeman, and J. E. Visvader. 2002. The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity. J. Biol. Chem. 277:7849–7856.
   PubMedGoogle Scholar
• Takemura, M., T. Kitagawa, S. Izuta, J. Wasa, A. Takai, T. Akiyama, and S. Yoshida. 1997. Phosphorylated retinoblastoma protein stimulates DNA polymerase alpha. Oncogene 15:2483–2492.
   PubMedGoogle Scholar
• Tang, B., E. P. Bottinger, S. B. Jakowlew, K. M. Bagnall, J. Mariano, M. R. Anver, J. J. Letterio, and L. M. Wakefield. 1998. Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat. Med. 4:802–807.
   PubMed Web of Science ®Google Scholar
• Wang, J. H., A. Nichogiannopoulou, L. Wu, L. Sun, A. H. Sharpe, M. Bigby, and K. Georgopoulos. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5:537–549.
   PubMed Web of Science ®Google Scholar
• Wong, A. K., P. A. Ormonde, R. Pero, Y. Chen, L. Lian, G. Salada, S. Berry, Q. Lawrence, P. Dayananth, P. Ha, S. V. Tavtigian, D. H. Teng, and P. L. Bartel. 1998. Characterization of a carboxy-terminal BRCA1 interacting protein. Oncogene 17:2279–2285.
   PubMed Web of Science ®Google Scholar
• Xu, X., K. U. Wagner, D. Larson, Z. Weaver, C. Li, T. Ried, L. Hennighausen, A. Wynshaw-Boris, and C. X. Deng. 1999. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet. 22:37–43.
   PubMed Web of Science ®Google Scholar
• Ye, X., A. A. Franco, H. Santos, D. M. Nelson, P. D. Kaufman, and P. D. Adams. 2003. Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest. Mol. Cell 11:341–351.
   PubMedGoogle Scholar
• Yu, X., and R. Baer. 2000. Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor. J. Biol. Chem. 275:18541–18549.
   PubMedGoogle Scholar
• Yu, X., L. C. Wu, A. M. Bowcock, A. Aronheim, and R. Baer. 1998. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273:25388–25392.
   PubMed Web of Science ®Google Scholar
• Zheng, L., and W.-H. Lee. 2002. Retinoblastoma tumor suppressor and genome stability. Adv. Cancer Res. 85:13–50.
   PubMedGoogle Scholar